|Articles|June 25, 2019
- Pharmaceutical Commerce - June 2019
- Volume 14
- Issue 2
2019 Supplier Spotlight
Advertisement
Articles in this issue
over 6 years ago
Fresh technology enlivens the pharma traceability sceneover 6 years ago
A Conversation with Greg Cathcart, Excellis Health Solutionsover 6 years ago
A Conversation with Ara Ohanian, Systech Internationalover 6 years ago
The Interoperability Illusionover 6 years ago
Pharma traceability: Marching toward 2023 go-liveover 6 years ago
New reverse-logistics capacity in Illinoisover 6 years ago
John Gray hangs up his spurs as head of HDANewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novo Nordisk’s Bloomington Plant Receives FDA OAI Designation Following Contamination and Compliance Issues
2
United States Delays Tariffs on Singapore’s Pharma Exports Amid Ongoing Trade Negotiations
3
Pharma Pulse: Kaiser Permanente Strike Escalates, Takeda Partners with Nabla Bio, and FDA Flags Novo Nordisk Bloomington Site
4
From Volume to Value: Rethinking What Drives Better Health Outcomes
5
